Advanced Filters
noise
Found 65,199 clinical trials
R Rebecka Levenskog

A Study Regarding Tissue Response During and After Treatment for Anal Cancer

The aim of this study is to improve the understanding for the tumour biology in relation to treatment response in patients with anal cancer by examining: The tumour microenvironment The localisation of and cellular interactions between the tumour and immune cells The gene and protein expression by cells present in …

18 years of age All Phase N/A
T Tasneem Kh Fouad, Bachelor

Impact of Tensor Fascia Lata Stretch on Vastus Medialis Obliqus Activity

Patellofemoral pain syndrome (PFPS) is one of the most typical causes of anterior knee pain in adolescents and young adults under the age of 50.It is believed that imbalanced action between quadriceps components, is the most contributing cause of PFPS.Investigating exercises that increase VMO muscle activation and enhance the ratio …

18 - 30 years of age All Phase N/A
Z Zhimin Shao, M.D.

The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer

This study is a single-center, prospective/retrospective, observational clinical research designed to compare the differences in peripheral blood components between young and elderly HR+HER2- breast cancer patients, and to identify peripheral blood components that may affect the prognosis of young HR+HER2- breast cancer patients. The study population consists of early-stage HR+HER2- …

18 years of age Female Phase N/A
H Haonan Yu, MD

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

To evaluate the potential usefulness of 68Ga/18F-Exendin 4 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various GLP-1R-related disease patients.

18 - 80 years of age All Phase N/A
G Giulia T Giulia Tasca, MD

Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario

This is a retrospective and prospective, multicenter, observational, two-cohorts study aimed to evaluate clinical outcomes and safety of patients diagnosed with advanced high grade ovarian cancer whose tumor was tested for the homologous recombination (HR) status using a validated HR deficiency test between January 2021 and January 2026. Cohort A: …

18 years of age Female Phase N/A
C Christian-Hendrik Heeger, Prof. Dr.

COCONUT Study Concomitant PVI and LAAC

In patients with non-valvular AF, at high stroke risk, and who are ineligible for long-term oral anticoagulation LAAC could be an alternative to anticoagulation and safety and efficacy has been shown in several studies and registries.8 While PVI and LAAC are both conducted in the left atrium and share the …

years of age All Phase N/A
R Rece Foss

Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot

One third of women with gestational diabetes (GDM), diabetes diagnosed during pregnancy, have abnormal glucose levels within 3 years after pregnancy, but follow up is low. Continuous glucose monitors (CGM), a small sensor inserted under the skin, may be able to screen women with GDM for diabetes risk. The investigators …

18 - 50 years of age Female Phase N/A
S Simona Marzi, Doctor

Repeatability and Reproducibility of the ADC Map in Head and Neck Cancer. Prospective Multicenter Study

Evaluation of the repeatability and reproducibility of ADC maps in both primary and non-primary lesions lymph nodes in patients with head and neck cancer, using an acquisition protocol Standardized DWI

18 years of age All Phase N/A
B Binafsha M Syed

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC

years of age Female Phase N/A
G Giulia Cenci

EIM Via the Myolex MScan As an ALS Biomarker

Amyotrophic lateral sclerosis (ALS) has been traditionally considered incurable and untreatable. But starting in the 1990s with the introduction of Riluzole, therapies are being discovered and ultimately approved for slowing disease progression. Many pharmaceutical companies continue to seek new therapeutic approaches. One critical aspect of all clinical trials is the …

18 years of age All Phase N/A

Simplify language using AI